That is a good point. I am going long today
All your so called "work" is going to bankrupt you....mark this post and I want an honest apology when this thing blows up.
Dr. - You so called "investors" are just a group of pumpers who pump eachother to the point of blindness. You guys don't like dissenting opinion but the reality is you're losing money in SNTA hand over fist. I'm telling you this drug is bunk. The way they are studying subsets of patients is completely bogus. They went on a fishing expedition and found something that possibly looks like it works. The biotech industry is littered with these bogus drugs. Since it's the only thing of real value in the pipeline, management "doubles down" to keep the company alive so they can collect paychecks. Meanwhile, institutions dump their shares onto chat board support groups who hope and pray their long shot comes through. Reality is that you have more chance of winning Powerball than this drug working.
Institutional sellers moving in again as we approach the close...face the facts Dr.
I'm telling you...it's $2, not $15
Ignore me at your own peril...just trying to help the little guy here...I guarantee SNTA is headed much, much, lower. Sell now or pay the price.
That's right dude...biotechs are down...keep up the optimism
I told you guys to get out and was bashed...no you are going to pay the price for not listening to the voice of reason
I agree...NIHD = the next NFLX
Apparently you care
I told you institutions would be dumping
Ashamed? I'm just trying to help the little guy here. The sell-side / institutional dynamic is real. Little guy needs fair warining. GLTA
Deep down, you know it's true...it's how the Street works
before it craters to sub-$1.00...and you longs are the bag-holders buying from Roth's institutional clients....don't do it
Heard they were going to sell some towers
When BMO Capital downgraded the stock, they MUST have talked to management is advance, just to get the lay of the land on the sudden departure. Clearly, management had little to say and the analyst was left very uncomfortable with the explanation. Managemen't radio-silence is the issue here. All they need to do is address the issue and put it behind them. The fact they haven't is either poor management or confirmation that the Street's worst fears are true.
Maybe becasue the stock has been almost cut in half since the departure announcement and management's radio-silence is only adding fuel to the fire....could taht be a good reason...I don't know, maybe it could.
I am begging you to sell your shares before you lose it all....fyi, I have no position in SNTA, I'm just a nice giy trying to help out a fellow investor who made a bad decision and hopefully won't go down with the ship
Easy there...I'm just trying to help you out and save you some coin. Here's from the 8-K. This should shock and long into sense, but somehow, the long bag-holders here seem to think this is GOOD news....plus management radio-silence pretty much says it all...
On May 5, 2013, Dr. Sumant Ramachandra resigned, effective immediately, as President, Research and Development of Synta Pharmaceuticals Corp. for personal reasons.
You are about to get crushed in SNTA. When a chief scientist leaves shortly before data are released, that is tell-tale sign the data are horrible. If that weren't the case, management would clarify what is meant by "personal reasons." You are going to be kicking yourself soon, saying, "why, oh why didn't I see the writing on the wall?"